Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease.

Front Endocrinol (Lausanne) · 2022 · PMC9441565 · PMID 36072931

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP >0.05actually significant

There was a trend toward a decrease in TG and HDL in the metformin group after treatment but this did not reach statistical significance (all P >0.05).

also in 111,027 other papers

showed a trendno p-value reported

The average IHL content was 42.11% in the sitagliptin group at 24 weeks which showed a trend decrease compared with baseline without statistical significance ( P > 0.05).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.